Skip to content
Search

Latest Stories

WHO rejects tobacco companies' harm reduction claims in a new report

WHO rejects tobacco companies' harm reduction claims in a new report
The WHO condemns tobacco companies' targeting of children through social media and flavored products

The World Health Organization (WHO) reiterated its concerns about tobacco companies' continued targeting of young people through various channels such as social media, sports, and music festivals, as well as the introduction of flavored products.

In a joint report with industry watchdog STOP released on Thursday, the WHO accused these companies of attempting to ensnare a new generation in nicotine addiction.


While facing stricter regulations on traditional cigarettes, major tobacco firms and newcomers have turned to alternatives like vapes, arguing they are intended for adult smokers.

However, the WHO and STOP highlighted in their report that these products often appeal to youth, with their attractive designs and fruity flavors making them more appealing to children than to adults in many countries.

WHO Director-General Tedros Adhanom Ghebreyesus dismissed the industry's claims of harm reduction, asserting that it's misleading to discuss harm reduction while marketing to children.

He stated in the report, "It's dishonest to talk about harm reduction when they are marketing to children."

This stern stance from the WHO comes as youth vaping rates soar globally.

Flavors like bubblegum have been identified as drivers of this trend, although the industry maintains that flavors play a crucial role in persuading adults to transition from smoking.

While large tobacco companies have largely refrained from offering such flavors, the WHO pointed out that firms like Philip Morris International (PMI) and British American Tobacco (BAT) engage in youth-oriented marketing tactics, including sponsoring music and sports events and leveraging social media.

Both PMI and BAT stated their intentions to shift smokers away from cigarettes, with BAT emphasising responsible marketing principles and ensuring products are for adults only.

PMI stressed the importance of scientifically substantiated smoking alternatives and expressed willingness to engage with governments and the WHO on the matter.

Despite these assertions, the WHO highlighted insufficient evidence supporting vapes as smoking cessation aids and pointed out evidence suggesting an increase in traditional cigarette use, particularly among youth, due to vaping.

However, Sarah Jackson from University College London's Tobacco and Alcohol Research Group disputed these claims, stating to Reuters that they do not accurately represent current evidence on e-cigarettes.

More For You

Hay fever treatment: Dymista nasal spray now available in pharmacies without prescription

Hay fever affects one in four people in the UK

gettyimages

Hay fever treatment: First OTC combination nasal spray launched

For the first time, a double-action combination treatment for moderate to severe hay fever has been available over the counter across UK pharmacies, offering a new option for those sufferers who remain uncontrolled on a corticosteroid or antihistamine nasal spray.

Launched by global healthcare company Viatris, Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray— previously only available via prescription under the brand name Dymista — can be accessed without a GP visit.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less